收稿日期: 2020-01-31
网络出版日期: 2022-07-14
基金资助
国家重点研发计划“精准医学研究”重点专项(2016YFC0905600-2016YFC0905601)
张伯玮, 任静, 马睿, 门剑龙 . D-二聚体在静脉血栓栓塞症诊疗中的应用临床实践[J]. 诊断学理论与实践, 2020 , 19(05) : 469 -473 . DOI: 10.16150/j.1671-2870.2020.05.005
[1] | 中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国非栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14):1060-1087. |
[2] | 《中国血栓性疾病防治指南》专家委员会. 中国血栓性疾病防治指南[J]. 中华医学杂志, 2018, 98(36):2861-2888. |
[3] | Singh B, Parsaik AK, Agarwal D, et al. Diagnostic accuracy of pulmonary embolism rule-out criteria: a systema-tic review and meta-analysis[J]. Ann Emerg Med, 2012, 59(6):517-520,e1-e4. |
[4] | Geersing GJ, Zuithoff NP, Kearon C, et al. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis[J]. BMJ, 2014, 348:g1340. |
[5] | Bass AR, Fields KG, Goto R, et al. Clinical decision rules for pulmonary embolism in hospitalized patients: a systematic literature review and meta-analysis[J]. Thromb Haemost, 2017, 117(11):2176-2185. |
[6] | Fabiá Valls MJ, van der Hulle T, den Exter PL, et al. Performance of a diagnostic algorithm based on a prediction rule, D-dimer and CT-scan for pulmonary embolism in patients with previous venous thromboembolism. A systematic review and meta-analysis[J]. Thromb Haemost, 2015, 113(2):406-413. |
[7] | Schouten HJ, Geersing GJ, Koek HL, et al. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis[J]. BMJ, 2013, 346:f2492. |
[8] | van Es N, van der Hulle T, van Es J, et al. Wells rule and d-Dimer testing to rule out pulmonary embolism: a systematic review and individual-patient data meta-analysis[J]. Ann Intern Med, 2016, 165(4):253-261. |
[9] | Righini M, van Es J, den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study[J]. JAMA, 2014, 311(11):1117-1124. |
[10] | Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism[J]. Eur Heart J, 2014, 35(43):3033-3069. |
[11] | Wilts IT, Le Gal G, den Exter PL, et al. PO-29 - age-adjusted D-dimer cutoff level increases the number of cancer patients in who pulmonary embolism can be safely excluded without CT-PA imaging: The ADJUST-PE cancer substudy[J]. Thromb Res, 2016, 140(Suppl 1):S187. |
[12] | Di Nisio M, Squizzato A, Rutjes AW, et al. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review[J]. J Thromb Haemost, 2007, 5(2):296-304. |
[13] | Carrier M, Righini M, Djurabi RK, et al. VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies[J]. Thromb Haemost, 2009, 101(5):886-892. |
[14] | Bates SM, Takach Lapner S, Douketis JD, et al. Rapid quantitative D-dimer to exclude pulmonary embolism: a prospective cohort management study[J]. J Thromb Haemost, 2016, 14(3):504-509. |
[15] | Clinical and Laboratory Standards Institute. Quantitative D-dimer for the exclusion of venous thromboembolism disease[R]. Approved guideline(H59-A), 31(6):15-17. |
[16] | Kearon C, Akl EA, Ornelas J, et al. Antithrombotic the-rapy for VTE disease: CHEST Guideline and Expert Panel Report[J]. Chest, 2016, 149(2):315-352. |
[17] | Ulrych J, Kvasnicka T, Fryba V, et al. 28 day post-operative persisted hypercoagulability after surgery for benign diseases: a prospective cohort study[J]. BMC Surg, 2016, 16:16. |
[18] | Kimura Y, Oki E, Ando K, et al. Incidence of venous thromboembolism following laparoscopic surgery for gastrointestinal cancer: a single-center, prospective cohort study[J]. World J Surg, 2016, 40(2):309-314. |
[19] | Kodama J, Seki N, Fukushima C, et al. Postoperative decreased levels of D-dimer in patients with gynecologic cancer with enoxaparin and fondaparinux thromboprophylaxis[J]. Mol Clin Oncol, 2013, 1(4):737-744. |
[20] | Lin Y, Liu Z, Qiu Y, et al. Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: a systematic review and meta-analysis[J]. Eur J Surg Oncol, 2018, 44(10):1494-1503. |
[21] | Li W, Tang Y, Song Y, et al. Prognostic role of pretreatment plasma D-Dimer in patients with solid tumors: a systematic review and meta-analysis[J]. Cell Physiol Biochem, 2018, 45(4):1663-1676. |
[22] | Simes J, Robledo KP, White HD, et al. D-dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease: LIPID study[J]. Circulation, 2018, 138(7):712-723. |
[23] | Jara-Palomares L, Solier-Lopez A, Elias-Hernandez T, et al. D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis[J]. Br J Cancer, 2018, 119(8):915-921. |
[24] | Ay C, Dunkler D, Marosi C, et al. Prediction of venous thromboembolism in cancer patients[J]. Blood, 2010, 116(24):5377-5382. |
[25] | Bjøri E, Johnsen HS, Hansen JB, et al. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence[J]. J Thromb Haemost, 2017, 15(5):917-924. |
[26] | Thaler J, Ay C, Pabinger I. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials[J]. Thromb Haemost, 2012, 108(6):1042-1048. |
[27] | 门剑龙, 钟殿胜, 任静. 血栓标志物评估恶性肿瘤患者静脉血栓风险[J]. 中华肿瘤杂志, 2015, 37(4):283-289. |
[28] | Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer[J]. J Am Coll Cardiol, 2017, 70(19):2411-2420. |
[29] | Kearon C, Parpia S, Spencer FA, et al. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; a cohort study[J]. J Thromb Haemost, 2019, 17(7):1144-1152. |
[30] | Zia A, Russell J, Sarode R, et al. Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: a systematic review and meta-analysis[J]. Thromb Res, 2017, 160:1-8. |
[31] | Johnson ED, Schell JC, Rodgers GM. The D-dimer assay[J]. Am J Hematol, 2019, 94(7):833-839. |
[32] | Verhovsek M, Douketis JD, Yi Q, et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism[J]. Ann Intern Med, 2008, 149(7):481-490,W94. |
[33] | Douketis J, Tosetto A, Marcucci M, et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis[J]. BMJ, 2011, 342:d813. |
[34] | Kearon C, Spencer FA, O'Keeffe D, et al. D-dimer tes-ting to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study[J]. Ann Intern Med, 2015, 162(1):27-34. |
[35] | Prandoni P, Vedovetto V, Ciammaichella M, et al. Resi-dual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis[J]. Thromb Res, 2017, 154:35-41. |
[36] | Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society(ERS)[J]. Eur Heart J, 2020, 41(4):543-603. |
[37] | Morelli F, Schol-Gelok S, Arends LR, et al. Effect of antiplatelet drugs on D-dimer levels: a systematic review and meta-analysis[J]. J Cardiovasc Pharmacol, 2019, 73(6):343-351. |
/
〈 |
|
〉 |